References
- Farr M, Garvey K, Bold AM, et al. Significance of the hydrogen ion concentration in synovial fluid in rheumatoid arthritis. Clin Exp Rheumatol 1985;3:99–104
- Steen KH, Steen AE, Reeh PW. A dominant role of acid pH in inflammatory excitation and sensitization of nociceptors in rat skin, in vitro. J Neurosci 1995;15:3982–9
- Lardner A. The effects of extracellular pH on immune function. J Leukoc Biol 2001;69:522–30
- Supuran CT. Carbonic anhydrases: novel therapeutic applications for inhibitors and activators. Nat Rev Drug Discov 2008;7:168–81
- Chang X, Han J, Zhao Y, et al. Increased expression of carbonic anhydrase I in the synovium of patients with ankylosing spondylitis. BMC Musculoskelet Disord 2010;11:279–90
- Zheng Y, Wang L, Zhang W, et al. Transgenic mice over-expressing carbonic anhydrase I showed aggravated joint inflammation and tissue destruction. BMC Musculoskelet Disord 2012;13:256–65
- Deutsch O, Krief G, Konttinen YT, et al. Identification of Sjögren's syndrome oral fluid biomarker candidates following high-abundance protein depletion. Rheumatology (Oxford) 2015;54:884–90
- Liu C, Wei Y, Wang J, et al. Carbonic anhydrases III and IV autoantibodies in rheumatoid arthritis, systemic lupus erythematosus, diabetes, hypertensive renal disease, and heart failure. Clin Dev Immunol 2012;2012:354594
- Maggi L, Margheri F, Luciani C, et al. Th1-induced CD106 expression mediates leukocytes adhesion on synovial fibroblasts from juvenile idiopathic arthritis patients. PLoS One 2016;11:e0154422
- Lindskog S, Nyman PO. Metal-binding properties of human erythrocyte carbonic anhydrases. Biochim Biophys Acta 1964;85:462–74
- Lindskog GE. A note concerning AmbroiseParé's Dix Livres de la Chirurgie. Surgery 1971;70:452–4
- Alterio V, Hilvo M, Di Fiore A, et al. Crystal structure of the catalytic domain of the tumor-associated human carbonic anhydrase IX. Proc Natl Acad Sci USA 2009;106:16233–8
- Khalifah RG, Edsall JT. Carbon dioxide hydration activity of carbonic anhydrase: kinetics of alkylated anhydrases B and C from humans. Proc Natl Acad Sci USA 1972;69:172–6
- Alterio V, Di Fiore A, D’Ambrosio K, et al. Multiple binding modes of inhibitors to carbonic anhydrases: how to design specific drugs targeting 15 different isoforms? Chem Rev 2012;112:4421–68
- Supuran CT. Structure-based drug discovery of carbonic anhydrase inhibitors. J Enzyme Inhib Med Chem 2012;27:759–72